Case 1:17-cv-00072-UNA Document 4 Filed 01/25/17 Page 1 of 1 PagelD #: 64
`
`TRADEMARK
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDINGA PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the U.S. District Court
`for the District of Delaware
`on the following
`() Trademarksor
`(7 Patents.
`( L the patent action involves 35 U.S.C. § 292.):
`
`SHIONOGI INC. and ANDRX LABS, L.L.C.
`
`DEFENDANT
`
`AUROBINDO PHARMALTD. and AUROBINDO
`PHARMA USA,INC.
`
`Andrx Labs, L.L.C.
`HOLDER OF PATENT OR TRADEMARK
`
`PATENT OR
`
`DATE OF PATENT
`
`1 6,790,459
`
`2 6,866,866
`
`9/14/2004
`
`Andrx Labs,L.L.C.
`
`3/15/2005
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO.
`
`LC] Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`LC Answer
`
`CL CrossBill
`
`CL] Other Pleading
`
`In the above—entitled case, the following decision has been rendered or judgementissued:
`
`DECISION/JUDGEMENT
`
`CLERK
`
`(BY) DEPUTY CLERK
`
`DATE
`
`Copy 1—Uponinitiation of action, mail this copy to Director Copy 3—Upontermination of action, mail this copy to Director
`Copy 2—Uponfiling document adding patent(s), mail this copy to Director Copy 4—Casefile copy
`
`AUROBINDOEX. 1006, 1
`
`AUROBINDO EX. 1006, 1
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFIGE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box
`450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`
`
`APPLICATION NUMBER
`
`09/705,625
`
`96056
`Florek & Endres PLLC
`
`1156 Avenue ofthe Americas
`
`Suite 600
`New York, NY 10036
`
`
`
`
`FILING OR 371(C) DATE
`
`FIRST NAMED APPLICANT
`
`ATTY. DOCKET NO./TITLE
`
`11/03/2000
`
`Xiu Xiu Cheng
`
`141-603
`CONFIRMATION NO. 6705
`
`POA ACCEPTANCE LETTER
`
`INOUE
`
`000000044246696
`
`Date Mailed: 10/29/2010
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorneyfiled 10/22/2010.
`
`The Power of Attorney in this application is accepted. Correspondencein this application will be mailed to the
`above address as provided by 37 CFR 1.33.
`
`/yvan/
`
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`AUROBINDOEx. 1006, 2
`
`AUROBINDO EX. 1006, 2
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFIGE
`
`
`
`
`
`
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`)
`OX. 450
`Address: COMMISSIONER FOR PATENTS
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`09/705,625
`
`11/03/2000
`
`Xiu Xiu Cheng
`
`141-603
`CONFIRMATION NO. 6705
`
`47888
`HEDMAN & COSTIGAN, P.C.
`
`1230 AVENUE OF THE AMERICAS
`
`7th floor
`NEW YORK, NY 10020
`
`POWEROF ATTORNEYNOTICE
`
`IOC000000044246610
`
`Date Mailed: 10/29/2010
`
`NOTICE REGARDING CHANGE OF POWEROF ATTORNEY
`
`This is in response to the Power of Attorneyfiled 10/22/2010.
`
`* The Power of Attorney to you in this application has been revoked by the assignee who hasintervened as
`provided by 37 CFR 3.71. Future correspondencewill be mailed to the new address of record(37 CFR 1.33).
`
`/yvan/
`
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`AUROBINDOEx. 1006, 3
`
`AUROBINDO EX. 1006, 3
`
`

`

`PTO/SB/80 (11-08)
`Approved for use through 11/30/2011. OMB 0651-0035
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no personsare required to respond to a collection of information unlessit displays a valid OMB control number.
`
`POWER OF ATTORNEYTO PROSECUTE APPLICATIONS BEFORE THE USPTO
`
`| hereby revokeall previous powers of attorney given in the application identified in the attached statement under
`37 CFR 3.73(b).
`| hereby appoint:
`
`
`
`
`
`
`
`
`
`Practitioners associated with the Customer Number:
`OR
`[| Practitioner(s) named below (if more than ten patent practitioners are to be named, then a customer number mustbe used):
`
`Name
`Registration
`Number
`
`Registration
`Number
`
`96056
`
`as attorney(s) or agent(s) to represent the undersigned before the United States Patent and Trademark Office (USPTO)in connection with
`any andall patent applications assigned only to the undersigned according to the USPTO assignmentrecords or assignment documents
`attached to this form in accordance with 37 CFR 3.73(b).
`
`Please change the correspondence addressfor the application identified in the attached statement under 37 CFR 3.73(b)to:
`
`
`
`
`
`The address associated with Customer Number:
`
`96056
`
`
`
`
`
`
`
`
`
`
`OR
`
`Firm or
`Individual Name
`Address
`
`
`
`City
`
`
`
`
`Country
`
`Telephone
`
`
`
`
`Assignee Name and Address:
`
`
`Andrx Labs, LLC
`
`4955 Orange Drive
`Davie, Florida 33314
`
` A copyofthis form, together with a statement under 37 CFR 3.73(b) (Form PTO/SB/96 or equivalent) is required to be
`
`filed in each application in which this form is used. The statement under 37 CFR 3.73(b) may be completed by oneof
`
`the practitioners appointed in this form if the appointed practitioner is authorized to act on behalf of the assignee,
`and mustidentify the application in which this Powerof Attorney is to befiled.
`
`
`
`SIGNATUREof Assignee of Record
`
`The individual whose signatureandtitle is supplied below is authorized to act on behalfofthe assignee
`
`
`
`
`
`
`
`
`
`
`
`
`Senior VP/ General Counsel
`Title
`This collection of information is required by 37 CFR 1.31, 1.32 and 1.33. The informationis required to obtain or retain a benefit by the public whichis tofile (and
`by the USPTOto process)an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 3 minutes
`to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Timewill vary depending uponthe individual case. Any
`comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
`U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMSTO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`lf you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`AUROBINDO Ex. 1006, 4
`
`AUROBINDO EX. 1006, 4
`
`

`

`Electronic AcknowledgementReceipt
`
`Title of Invention:
`
`METHODS FOR TREATING DIABETES VIA ADMINISTRATRION OF CONTROLLED
`RELEASE METFORMIN
`
`First Named Inventor/Applicant Name:
`
`International Application Number: Bd
`
`
`
`Application Type:
`
`Utility under 35 USC 111(@
`
`Paymentinformation:
`
`File Listing:
`
`5)
`
`Pages
`Multi
`File Size(Bytes)/
`DocumentDescription
`Document
`
`
`
`Number Message Digest|Part/.zip|P (if appl.)
`
`Assignee showing of ownership per 37
`CFR 3.73(b).
`
`6790459statement.pdf
`
`4f7cf085fe48c54331 fb95ebf3da307c8c460
`ef6
`
`e:
`
`Information
`
`AUROBINDO EX. 1006,
`
`AUROBINDO EX. 1006, 5
`
`

`

`Power of Attorney
`
`AndrxLabsPOA.pdf
`
`171203
`
`a2c5c2c827e09c383c1 e79893ffb0cc5247a
`Od9
`
`the application.
`
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shownon this AcknowledgementReceiptwill establish the international filing date of
`
`This AcknowledgementReceipt evidences receipt on the noted date by the USPTOofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`AcknowledgementReceiptwill establish thefiling date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptanceof the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`AUROBINDOEX. 1006, 6
`
`AUROBINDO EX. 1006, 6
`
`

`

`STATEMENT UNDER37 CER 3.73(b)
`
`Titled:me
`
`METHODS FOR TREATING DIABETES VIA ADMINISTRATION OF CONTROLLED RELEASE METFORMIN
`
`Filed/lssue Date: September 14, 2004
`
`Andrx Labs, LLC
`(Name of Assignee}
`
`states thatit is:
`
`a
`
`corporation
`{Type of Assignee, e.g., corporation, partnership, university, government agency,etc.
`
`4.
`
`the assigneeof the entire right, title, and interest in;
`
`an assignee of less than the entire right,title, and interest in
`(The extent (by percentage)ofits ownership interest is
`
`%); or
`
`the assignee of an undivided interest in the entirety of {a complete assignment from one of the joint inventors was made)
`3. []
`the patent application/patent identified above, by virtue of either:
`
`A.[] An assignment from the inventor(s) of the patent application/patentidentified above. The assignment was recordedin
`the United States Patent and Trademark Office at Reel
`, Frame
`, or for which a
`copy therefore is attached.
`
`OR
`
`A chain oftitle from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`4. From: %. Cheng, C.Chen, S. Jan, J.Chou
`To: ANDRX CORPORATION
`
`The document was recorded in the United States Patent and Trademark Office at
`Reel 011687
`,
`Frame 9690
`,
`or for which a copy thereofis attached.
`
`2.From:
`
`Andrx Corporation, A Florida Corporation
`
`To: Andrx Corporation, A Delaware Corporation
`
`The document was recorded in the United States Patent and Trademark Office at
`Ree| 913792
`,
`Frame 0227
`,
`or for which a copy thereof is attached.
`
`3.From:
`
`ANDRX CORPORATION
`
`To: ANDRX LABS, LLC
`
`The document was recorded in the United States Patent and Trademark Office at
`Reel 013788
`,
`Frame 0187
`,
`or for which a copy thereof is attached.
`
`[_]
`
`Additional documentsin the chainoftitle are listed on a supplemental sheet(s).
`
`As required by 37 CFR 3.73(b)(1\(i), the documentary evidence of the chain oftitle from the original owner to the assignee was,
`or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`(NOTE: A separate copy (ie., a true copy of the original assignment document{s)) must be submitted to Assignment Division in
`accordance with 37 CFR Part 3, to record the assignmentin the records of the USPTO. See MPEP 302.08]
`
`PTO/SB/96 (07-09)
`Approved for use through 07/31/2042. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unlessit displays a valid OMB control number.
`
`Applicant/Patent Owner: Xiu Xiu Cheng, Chih-Ming Chen, Steve Jan, Joseph Chou Application No./Patent No.: 6,790,459
`
`The undersigned (whose titleis votestow)isauthorizedtoacton behalfofthe assignee.
`eI
`
`Signature
`
`Ortobee 18. SOO
`
`Date
`
`David A. Buchen
`
`
`Senior VP/ General Counsel
`
`Title
`Printed or Typed Name
`This collection of information is required by 37 CFR 3.73(b). The information is required to obtain or retain a benefit by the public whichisto file (and by the USPTO to
`process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.41 and 1.44. This collection is estimated to take 12 minutes to complete, including
`gathering, preparing, and submitting the compteted application form to the USPTO. Timewill vary depending upon theindividual case. Any comments on the amount of time
`you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S.
`Department of Commerce, P.O. Box 7450, Alexandria, VA 22313-1450, DO NOT SEND FEES OR COMPLETED FORMSTO THIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`ifyou need assistance in completing the form, call 1-800-PTO-9199 and select option 2. AU RO B | N DO EX. 1 006, 7
`
`AUROBINDO EX. 1006, 7
`
`

`

`Page 1 of 1
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER ‘FOR PATENTS
`lexandris, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NUMBER
`09/705,625
`
`FILING OR371 (c) DATE
`11/03/2000
`
`FIRST NAMED APPLICANT
`Xiu Xiu Cheng
`
`ATTY. DOCKET NO/TITLE
`141-603
`
`47888
`
`HEDMAN & COSTIGANP.C.
`1185 AVENUE OF THE AMERICAS
`NEW YORK,NY 10036
`
`|
`
`|
`
`:
`
`CONFIRMATION NO. 6705
`
`AACA
`
`0c00000
`
`Date Mailed: 08/06/2007
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorneyfiled 07/23/2007.
`
`The Powerof Attorneyin this application is accepted. Correspondencein this application will be mailed to the
`above addressas provided by 37 CFR 1.33.
`
`
`
`Hh
`Office ofInitial Patent Examination (571) 272-4000, or 1-800-PTO-9199
`OFFICE COPY
`
`AUROBINDO Ex. 1006, 8
`
`AUROBINDO EX. 1006, 8
`
`

`

`Page 1 of 1
`
`
`
`ror
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent a
`rademar
`Address: COMMISSIONER FOR PATENTS
`.
`Alexandria, Virginia 22313-1450
`gov
`www.uspto
`
`APPLICATION NUMBER
`09/705,625
`
`FILING OR 371 (c) DATE
`11/03/2000
`
`FIRST NAMED APPLICANT
`Xiu Xiu Cheng
`
`ATTY. DOCKET NOJ/TITLE
`300.1012
`
`ase
`
`DAVIDSON, DAVIDSON & KAPPEL, LLC
`485 SEVENTH AVENUE, 14TH FLOOR
`NEW YORK, NY 10018
`
`| OECNC
`
`0000000
`
`CONFIRMATION NO. 6705
`
`Date Mailed: 08/06/2007
`
`NOTICE REGARDING CHANGE OF POWEROF ATTORNEY
`
`‘This is in response to the Power of Attorneyfiled 07/23/2007.
`
`e The Powerof Attorney to youin this application has been revoked by the assignee whohasintervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new addressof record(37 CFR 1.33).
`
`
`
`aO
`
`ffice of Initial Patent Examination (571) 272-4000, or 1-800-PTO-9199
`OFFICE COPY
`
`AUROBINDOEX. 1006, 9
`
`AUROBINDO EX. 1006, 9
`
`

`

`PTO/SB/21 (09-06)
`Approvedfor use through 03/31/2007. OMB 0651-0031
`
`T,
`
`09/705,625
`
`.
`
`So
`
`¥
`
`NULOU
`
`Licensing-related Papers
`
`Requestfor Refund
`
`CD, Numberof CD(s)
`[ Landscape Table on CD
`
`[10OOO
`
`Extension of Time Request
`
`Information Disclosure Statement
`
`OL
`
`Certified Copy of Priority
`Document(s)
`
`Reply to Missing Parts/
`Incomplete Application
`Reply to Missing Parts
`under 37 CFR 1.52 or 1.53
`
`
`Filing Date
`November3, 2000
`
`First Named Inventor
`Chengetal.
`
`Art Unit
`
`T. Ware
`ae
`Examiner Name
`
`
`.
`(to be usedfor all correspondenceafterinitial filing)
`Attorney Docket Number|444.693
`Total Number of Pages in This Submission
`
`ENCLOSURES—(Checkall that apply)
`[
`After Allowance Communication to TC
`
`
`Fee Transmittal Form
`Drawing(s)
`
`
`
`
`LJ
`Fee Attached
`Appeal Communication to Board
`of Appeals andInterferences
`
`
`[| Amendment/Reply
`.
`Appeal Communication to TC
`Petition
`(Appeal Notice, Brief, Reply Brief)
`
`[| Petition to Convert to a ; .
`
`
`[| After Final
`
`
`Provisional Application
`Proprietary Information
`L| Affidavits/declaration(s)
`Powerof Attorney, Revocation
`
`
`
`Change of Correspondence Address
`Status Letter
`
`
`[|
`Other Enclosure(s) (pleaseIdentify
`Terminal Disclaimer
`below):
`
`
`Statement Under 37 CFR 3.73 (b)
`
`
`Express Abandonment Request
`Return Receipt Postcard
`
`
`
`
`
`
`
`
`
`
`
`
`S00CLLOOOO
`
`
`
`
`
`
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT
`
`Firm Name
`
`HEDMAN& COSTIGAN, P.C.
`
`ZZ
`
`Printed
`
`
`
`
`
`
`
`CERTIFICATE OF TRANSMISSION/MAILING
`
`| hereby certify that this correspondenceis being facsimile transmitted to the USPTO or deposited with the United States Postal Service with
`sufficient postageasfirst class mail in an envelope addressed to: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450 on
`the date shown below:
`
`SeeaCD2
`
`Typed or printed name_—‘|Matthew J. Solow|Date: July 19, 2007
`
`Ly”
`
`3
`
`This collection of information is required by 37 CFR 1.5. The information is required to obtain or retain a benefit by the public which isto file (and by the USPTO to
`process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and1.14. This collection is estimated to 2 hours to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the
`amountof time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
`ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`AUROBINDO EX. 1006, 10
`
`AUROBINDO EX. 1006, 10
`
`

`

`v
`
`
`
`PTO/SB/81 (01-06)
`Approvedfor use through 12/31/2008. OMB 0651-0035
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`uired to respond to a collection of information. unlessit displays a valid OMB control number.
`Application Number
`09/705,625
`Filing Date
`November3, 2000
`
`
`
`
`
`
`
`POWER OF ATTORNEY
`
`
`
`and
`Methodsfor Treating Diabetes Via....
`
`
`
`CORRESPONDENCE ADDRESS
`|Artunit=sd1615
`
`
`
`INDICATION FORM
`
`| hereby revoke all previous powers of attorney given in the above-identified application.
`| hereby appoint:
`FA Practitioners associated with the Customer Number:
`OR
`[J Practitioner(s) named below:
`
`Attorney Docket Number
`
`141-603
`
`47888
`
`
`
`Registration Number
`
`as my/our attorney(s) or agent(s) to prosecute the application identified above, and to transact all business in the United States Patent and
`Trademark Office connected therewith.
`
`Please recognize or change the correspondence addressfor the above-identified application to:
`The address associated with the above-mentioned Customer Number:
`OR
`
`LJ
`The address associated with Customer Number:
`LIravine|sdIndividual Name
`
`OR
`
`ye
`
`AT
`
`elephone PP
`IAyApplicant/Inventor.
`
`Assigneeof record of the entire interest. See 37 CFR 3.71.
`Statement under 37 CFR 3.73(b) is enclosed. (Form PTO/SB/96)
`
`SIGNATUREof Applicant or Assignee of Record
`4
`[SignaturebbetaTeneratetyJOD_|
`|Name Roberta Loomar
`Telephone {954-762-6211
`Title and Company
`___|Vice President, Chief Compliance Officer and Assistant General Counsel; Andrx Corporation
`
`NOTE:Signaturesof all the inventors or assignees of record of the entire interest or their representative(s) are required. Submit multiple forms if more than one
`signature is required, see below*.
`
`forms are submitted.
`“Total of 1
`This collection of information is required by 37 CFR 1.31, 1.32 and 1.33. The information is required to obtain or retain a benefit by the public whichisto file {and by
`the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 3 minutes
`to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending uponthe individual case. Any
`comments on the amountof time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
`U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TOTHIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`AUROBINDOEX. 1006, 11
`
`AUROBINDO EX. 1006, 11
`
`

`

`w
`
`.
`
`
`PTO/SB/96 (04-07)
`Approved for use through 09/30/2007. OMB 0651-0031
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`e Paperwork Reduction Act of 1995, no personsare required to respond to a collection of information unlessit displays a valid OMB control number..
`
`
`
`
`
`
`
`
`
`Entitled: METHODS FOR TREATING DIABETES VIA ADMINISTRATION OF CONTROLLED RELEASE METFORMIN
`
`
`
`Applicant/Patent Owner:
`
`_Xiu Xiu Cheng etal.
`
`STATEMENT UNDER37 CER3.73(b)
`
`Application No./Patent No.:
`
`_6,790,459
`
`Filed/Issue Date:
`
`_September 14, 2004
`
`2. [Janassignee oftess than the entire right, title and interest
`
`OR
`
`[_] Additional documentsin the chain oftitle are listed on a supplemental sheet.
`
`CJ As required by 37 CFR 3.73(b)(1)(i), the documentary evidence of the chain oftitle from the original owner to the
`assignee was, or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`Division in accordance with 37 CFR Part 3, to record the assignmentin the records of the USPTO. See MPEP
`302.08]
`
`The undersignec.{whosetitle is supplied below) is authorized to act on behalf of the assignee.
`
`Seul 1) FOOF
`
`
`
`
`Andre Labs, LLC
`, a
`_Limited Liability Company
`(Type of Assignee, e.g., corporation, partnership, university, government agency, etc.)
`(Nameof Assignee)
`
`
`X
`
`
`states thatit is:
`
`
`
`
`1.
`the assignee of the entire right, title, and interest; or
`(The extent (by percentage) of its ownership interest is__._—=_«%)
`
`in the patent application/patentidentified above byvirtue of either:
`
`
`
`ALJAn assignment from the inventor(s) of the patent application/patent identified above. The assignment was recorded
`in the United States Patent and Trademark Office at Reel
`, Frame
`, or for which a copy
`
`
`thereof is attached.
`
`
`
`
`B[V] Achain oftitle from the inventor(s), of the patent application/patentidentified above, to the current assignee as follows:
`
`
`
`1. From: _XiuXiuChengetal SSCS: Ad Corporation
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel 011687
`, Frame _0690
`, or for which a copy thereofis attached.
`
`
`
`
`2. From:
`_Andrx Corporation, A Florida Corporation
`To: Andrx Corporation, A Delaware Corporation
`The document was recorded in the United States Patent and TrademarkOffice at
`
`
`
`Reel_013792 , Frame _0227 , of for which a copy thereofis attached.
`
`3. From: Andrx Corporation
`To; Andrx Labs, LLC
`The document was recorded in the United States Patent and Trademark Office at
`
`
`Reel
`_013788
`, Frame
`_0187
`, or for which a copythereofis attached.
`
`
`
`
`
`
`
`
`
` [NOTE:A separate copy(i.e., a true copy of the original assignment document(s)) must be submitted to Assignment
`
`
`
`
`
`
`
`
`
`Telephone Number
`
`
`
`Vice President, Chief Compliance Officer and Assistant General Counsel
`Title
`
`
`This collection of information is required by 37 CFR 3.73(b). The information is required to obtain or retain a benefit by the public whichis to file (and by the
`USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Timewill vary depending uponthe individual case. Any
`comments on the amountof time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
`U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMSTO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`
`
`
`Signature
`_...... Roberta Loomar
`
`.
`
`Date
`954-762-6211
`
`Printed or Typed Name
`
`if you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`AUROBINDOEX. 1006, 12
`
`AUROBINDO EX. 1006, 12
`
`

`

`JorFy
`
`ws 2
`300.1012
`J
`INTHEUNITED STATES PATENT & TRADEMARKOFFICE
`\
`«a
`QS‘>
`Vy
`<Oyy
`
`&Tee” Applicants: Xiu Xiu CHENG,etal.
`
`Serial No.:
`09/705,625
`
`Filed:
`
`For:
`
`November3, 2000
`
`METHODS FOR TREATING DIABETESVIA
`ADMINISTRATION OF CONTROLLED
`RELEASE METFORMIN
`
`Art Unit:
`
`1615
`
`RESPONSE TO NOTICE REGARDING DRAWINGS
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Sir:
`
`August 2, 2004
`
`In response to the Notice Regarding Drawings, dated June 21, 2004, Applicants submit
`
`replacement drawings, Figures 1-8.
`
`If any additional fees are deemedto be dueatthis time, the Commissioner is authorized
`
`to charge payment of the same to Deposit Account No. 50-0552.
`
`Respectfully submitted,
`
` Davidson, Davidson & Kappel, LLC
`
`485 Seventh Avenue, 14" Floor
`New York, NY 10018
`(212)736-1940
`
`AUROBINDOEX. 1006, 13
`
`AUROBINDO EX. 1006, 13
`
`

`

`}615
`©
`eres eo
`ey MEO 4 mm 3
`FORM PTO-1083
`zs
`
`=“ Date? August 2,2004_Ff, -
`es
`Ss
`COMMISSIONER FOR P ENTS
`&
`
`SParenes
`P.O. BOX 1450
`.
`DERE “
`Alexandria, VA 22313-1450
` ~—=—--
`
`“49> byUIP!
`
`
`
`Docket No.: 300.1012
`
`In re application of: Xiu Xiu CHENG, et al.
`Serial No.: 09/705,625
`Filed:
`November3, 2000
`For:
`METHODS FOR TREATING DIABETESVIA ADMINISTRATION
`OF CONTROLLED RELEASE METFORMIN
`
`Sir:
`
`Transmitted herewith is a Response to Notice Regarding Drawingsin the above-identified application.
`
`0 Small entity status of this application under 37 C.F.R. 1.9 and 1.27 has been
`established by a verified statement previously submitted.
`{] A verified statement to establish small entity status under 37 C.F.R. 1.9 and
`1.27 is enclosed.
`* [X] No fee for additional claims is required.
`{| A filing fee for additional claims calculated as shownbelow,is required:
`
`SEMAININGeaaeee RATE FEE OR RATE FEE
`
`
`
`
`
`eC(COL.1)(COD.2)Col. SMALL ENTITY LARGE ENTITY
`
`
`PREVIOUSLY]
`AFTER
`PAID FOR
`AMENDMENT]
`*
`Minus 20**
`=
`TOTAL CLAIMS
`0
`*
`Minus 3***
`=
`INDEP. CLAIMS|
`FIRST PRESENTATION OF MULTIPLE DEP. CLAIM
`
`PRESENT
`EXTRA
`
`91/5
`x §
`x §$ 42/5
`+ $1401/5
`
`|
`
`x $ 18(§
`x § 84|$
`+_$280|$
`
`TOTAL:
`
`$
`
`OR
`
`TOTAL:
`
`$
`
`1 is less than the entry in Col. 2, write "0" in Col. 3.
`If the entry in Co.
`If the “Highest Number Previously Paid For" IN THIS SPACE is less than 20, write "20" in this space.
`If the "Highest Number Previously Paid For" IN THIS SPACE is less than 3, write "3" in this space.
`
`Also transmitted herewith are:
`[ ] Petition for one-month extension under 37 C.F.R. 1.136 (in duplicate)
`[X}] Other: Eight sheets of drawings
`
`Check(s) in the amounts of $.00 is/are attached to cover:
`(|. Filing fee for additional claims under 37 C.F.R. 1.16
`1] Petition fee for one month extension under 37 C.F.R. 1.136
`[X] Other:
`
`The Assistant Commissioner is hereby authorized to charge paymentof the following fees associated with this
`communication or credit any overpayment to Deposit Account No. 50-0552. A duplicate copyof this sheetis
`enclosed.
`[X]
`Anyfiling fee under 37 C.F.R. 1.16 for the presentation of additional claims which are not paid by
`check submitted herewith.
`Any patent application processing fees under 37 C.F.R. 1.17.
`Any petition fees for extension under 37 C.F.R. 1.136 which are not paid by check submitted herewith,
`andit is hereby requested that this be a petition for an aut
`tic
`gxtensio
`ime under 37 CFR
`
`[X]
`[X]
`
`1.136.
`
`DAVIDSON, BAVIDSON & KAPPEL, LLC
`485 Seventh Avenue, 14" Floor
`New York, New York 10018
`(212) 736-1940
`
`*w
`
`k
`KK
`
`[X]
`
`[X]
`
`| hereby certify that this correspondence and/or documents referred to
`as attached therein and/or fee are being deposited with the United
`States Postal Service as “first class mail” in an envelope addressedto
`Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450”
`
`on_August 2, 2004 __.
`
`DAVIDSON, DAVIDSON & KAPPEL, LLC
`
`BY: < prrhitrse Lberete
`
`Guendoline Decosta
`
`AUROBINDO EX. 1006, 14
`
`AUROBINDO EX. 1006, 14
`
`

`

`METHODS FOR TREATING DIABETES
`VIA ADMINISTRATION OF CONTROLLE
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng, et al.
`09/705,625
`Application Serial No.:
`
`:
`~—-
`
`1/8
`
`
`
`000€
`
`002
`
`001
`
`000¢
`0001
`(qu/6u) ‘ONOOD VWSV1d
`
`00S
`
`SWIL21Zg|Shral6g€0
`
`(1y)
`
`
`
`
`
`--o--LOlaPIGJOVHdOONTOWW3UdMALAY‘PDLXNINYOSLINW—e—
`
`YANNIGMALYPDLXNINYOSLIW
`
`AUROBINDO EX. 1006, 15
`
`
`(‘pqBwgg)
`
`
`
`FDWHdOONTOYO(‘p'bBw0G9xZ)LXNINNOILSWJONOILVYLSININGYWuONVMaLdVSLOSPANSN3A373NININYOSLSW40S31NJONdSWIL-NOLLVULNJONODWWSV1dNVA
`
`
`
`
`
`AUROBINDO EX. 1006, 15
`
`
`

`

`“|
`
`METHODS FOR TREATING DIABETES
`VIA ADMINISTRATION OF CONTROLLED.
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng, et al.
`09/705,625
`Application Serial No.:
`
`2/8
`
`€Ol(1y)SWIL
`
`
`
`‘PT3OvHdOONTO-—~¥—WANYALAY‘PDLXNINYOILIIN—e—
`
`ve4OLcb8v0
`
`
`
`MANNIGY3Ly‘P’D1XNINYOSLIW--o--
`
`AUROBINDO EX. 1006, 16
`
`00S
`
`
`
`WHONVYALASLOAPENSSATAMLNININYOSLSW40S31IS0UdSIIL-NOILVYLNSONOOVS1dNYS
`
`
`
`
`
`000€
`
`00S¢
`
`001
`
`0002
`(qw/6u) ‘ONOO WWSV1d
`
`0001
`
` (pqBWOOSxZ)IDVHdOINTOHO(’p’bBw00Sx)LXNINYOILSW4ONOILVYLSININGY
`
`AUROBINDO EX. 1006, 16
`
`
`

`

`a2Of
`rgiw<<=>
`
`z26zui6re‘oo
`aWwWo-
`iear<6oOLe
`
`\
`
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng, et al.
`09/705,625
`Application Serial No.:
`
`}
`
`3/8
`
`€Old
`
`S&S
`So—
`
`S
`
`ONOOD WWSV1d
`
`oS
`S
`(quw/6u) “ONOD YWSV1d
`
`SAASTTTSTS(JY)SWIL
`SrOh6ehCUtCOCO0000yz02912}80esesaesaSieneeneeosSn||||
`
`
`(14)SWIL(14)SWILL
`
`
`
`
`AHLTW3HLHOIANININNOALSW40S3114OUdSWLL-NOLLVHLNSONOOWWSW1dNV3IN
`
`
`(‘p’bBw00¢Xp)LXNINYOILSWJOSASOdWHOJIdILINWYALsVSLOAraNs
`
`
`vbAV©SLAW«ZhAWG)=LLAVGOLAV|AVG
`
`
`000010000100001
`
`(quu/6u
`
`00010001
`
`(qu/6u)
`
`—_~—_~
`
`S
`
`-
`
`NOD WNSV1d
`
`AUROBINDOEX. 1006, 17
`
`AUROBINDO EX. 1006, 17
`
`
`

`

`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng,
`Application Serial No.:
`
`“aoywtu©a
`09/705,625
`|
`
`etal.
`
`uy<=>
`502=O«tzuoresfraHzOFzt
`
`
`
`(€2=")SLNSILVdWCCINNININNOSLAWJOS31I4OUdSWIL-NOLLVULNSONOOWS1dSLVLS-ACVALSNVA
`
`
`
`
`
`
`
`YO(YANNIGHLIM‘P’bBu0001XZ)LXNINYOSLAW40SASO0WHOS1dILINWYaLsy
`
`SAMbNOS(‘PTBw00LX1)JDVHAOONTD0008
`
`4/8
`
`yol
`
`
`
`ve02OLch8v0Po
`
`
`
`JOVHdOONTD--O--LXNINYO41LS—e—
`
`
`
`(14)SWIL
`
`00S¢
`
`000¢
`0051
`(qw/6u) “ONOO WNSV1d
`
`AUROBINDO EX. 1006, 18
`
`AUROBINDO EX. 1006, 18
`
`
`

`

`
`O2%s%
`
`pcueessre?
`
`eEL5s©races©
`Cnuss
`5558;
`
`BE8
`
`Qo
`
`Su88091
`Tee?081
`uwOrtwa
`
`
`
`
`(‘pqBwOOO!X1)INVHdOONTDYO(YSNNICHLIM‘P’>OOO!XZ)LXNINNOSLSW
`
`0rz
`
`022
`
`002
`
`(14)SILG‘C)lfwdgwe9wid9v202g|A8y0Le
`
`0Z1
`
`
`
`(€7="U)SDWHdOONTO--O--(€Z=")LXNINNOILIW—e—
`
`
`
`
`
`(qp/6w) “ONOD 3SO9N19 YWSV1d
`
`AUROBINDO EX. 1006, 19
`
`
`
`
`
`HLIMLNAWLVSYL40SWSSM7YSLSVSA1JONdSWIL-NOILVYLNSONODSSO9NT9YWWSV1dNVA
`
`
`
`
`
`AUROBINDO EX. 1006, 19
`
`
`

`

`
`
`(NOH)SWIL
`
`
`
`buco09¢——s—
`
`9Ol
`
`AUROBINDO EX. 1006, 20
`
`‘ D
`
`
`
`QZOzxiS=>
`
`i-FOafe<3oO2ZOzi6aSsfLo
`
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng, et al.
`09/705,625
`Application Serial No.:
`
`6/8
`
`SIOlG G’ZHdNI‘wdigyLyF1ddvd
`
`cl
`
`001
`(
`%)
`
`08
`
`09
`
`Ov
`
`02
`
`QsSsvailayd LNAOWY
`
`
`
`
`
`S341dO¥dNOLLMIOSSIGIOHNINYOILAN
`
`AUROBINDO EX. 1006, 20
`
`
`

`

`METHODS FOR TREATING DIABETES
`VIA ADMINISTRATION OF CONTROLLED
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng,
`etal.
`Application Serial No.:
`09/705,625
`
`7/8
`
`
`
`
`
`S31140YdNOLLNIOSSIGIOHNINYOSLIW
`
`G'ZHdNI‘WdigyLVJ1dGvd
`
`0¢ ZOld
`GlOLG
`
`
`
`(NOH)SIL
`
`i—
`
`021
`
`08
`
`09
`
`001
`%) GaSV413y LNNOWY
`~—
`
`Ov
`
`0¢
`
`AUROBINDOEX. 1006, 21
`
`AUROBINDO EX. 1006, 21
`
`
`

`

`9.
`
`~ *°
`
`®Xp;
`
`Ga
`
`PATENT
`
`
`
`<x30WUYAD,oy/»p
`
`as
`
`
`
`::S31140¥dNOILATOSSIGIDHNINHOALAN
`
`
`
`
`
`|GZNI‘WdigyLW310dvd
`
`|
`
`0zGhOLS
`
`METHODS FOR TREATING DIABETES
`VIA ADMINISTRATION OF CONTROLLE
`RELEASE METFORMIN
`Inventor:
`Xiu Xiu Cheng, et al.
`Application Serial No.:
`09/705,625
`
`8/8
`
`
`
`(%) Gasva1ay LNNOWY
`
`
`
`(YNOH)SWIL
`
`
`
`6wo000|——#—
`
`8Old
`
`AUROBINDOEX. 1006, 22
`
`AUROBINDO EX. 1006, 22
`
`

`

`
`
`.
`
`
`
`e
`e 8S
`lo —<
`*RETURN TO FMF - LOCATION 7540
`Re
`QUERY CONTROL FORM
`
`
`Application No. OF. 709 626
`Prepared by
`Examiner-GAU
` Tran— (6 LS
`Date
`
`No. of queries
`
`
`p. PTO-1449
`k. Print Claim(s)
`f. Foreign Priority
`a. Serial No.
`q. PTOL-85b
`1. Print Fig.
`g. Disclaimer
`b. Applicant(s)
`
`
`r. Abstract
`m. Searched Column
`h. Microfiche Appendix
`c. Continuing Data
`d. PCT
`i. Title
`n. PTO-270/328
`(Gheets/Figs
`
`
`
`
`e. Domestic Priority
`t. Other
`j. Claims Allowed
`0. PTO-892
`
`
`
`
`
`
`. Page Missing
` b. Text Continuity
` . Holes through Data
` . Other Missing Text
`
`. Illegible Text
`
`
`. Brief Description
`=a2. SequenceListing
`
`
`Appendix
`
`j. Amendments
`
` - Other
`
`
`. Claim(s) Missing
`
`. Improper Dependency
`QaOofF. Incorrect Numbering
` . Duplicate Numbers
` o. Index Disagrees
`
`
`
`. Amendments
`
`. Bracketing
` i. Missing Text
` j. Duplicate Text
`
`
`. Other
`
`
`
`
`SPECIFICATION
`
`~O29a0 Duplicate Text
`
`CLAIMS
`
`. Punctuation
`
`E-5 (Rev. 10/15/02)
`
`
`*LOCATION 7540
`
`AUROBINDOEX. 1006, 23
`
`AUROBINDO EX. 1006, 23
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARKOFFICE
`
`UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND
`DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NUMBER
`09/705625
`
`FILING/